Abstract
A nuclear protein of testis (NUT) carcinoma, also known as NUT midline carcinoma, is a rare subtype of squamous carcinoma known for its aggressive growth behaviour. It can form anywhere in the body. Although, it usually occurs along midline structures (head, neck, lungs). The authors present the first report of intrasellar NUT carcinoma with cavernous sinus infiltration in a 47-year-old patient. MRI showed an inhomogeneous, gadolinium-enhancing lesion with intra- and suprasellar growth, invasion of the cavernous sinus without clear differentiation from normal pituitary tissue. Given the lymphoma diagnosis in the frozen section and invasion of the cavernous sinus, the patient underwent endoscopic, transnasal, and transsphenoidal subtotal resection only. Local tumour and spinal metastases showed a good response to radio-chemotherapy. Despite combined radio-chemotherapy, the patient died of pulmonary insufficiency due to rapid progression of pulmonary metastasis 6 months after the initial diagnosis.
Similar content being viewed by others
Data availability
The data that support the findings of this study are available on request from the corresponding author [LT]. The data are not publicly available due to restrictions (e.g., these contain information that could compromise the privacy of research participants).
Abbreviations
- NUT:
-
Nuclear protein of testis
- MRI:
-
Magnetic resonance imaging
- HDACi:
-
Histone deacetylase inhibitors
References
Bauer DE, Mitchell CM, Strait KM, Lathan CS, Stelow EB, Luer SC, Muhammed S, Evans AG, Sholl LM, Rosai J, Giraldi E, Oakley RP, Rodriguez-Galindo C, London WB, Sallan SE, Bradner JE, French CA (2012) Clinicopathologic features and long-term outcomes of NUT midline carcinoma. Clin Cancer Res 18:5773–5779. https://doi.org/10.1158/1078-0432.CCR-12-1153
Chau NG, Hurwitz S, Mitchell CM, Aserlind A, Grunfeld N, Kaplan L, Hsi P, Bauer DE, Lathan CS, Rodriguez-Galindo C, Tishler RB, Haddad RI, Sallan SE, Bradner JE, French CA (2016) Intensive treatment and survival outcomes in NUT midline carcinoma of the head and neck. Cancer 122:3632–3640. https://doi.org/10.1002/cncr.30242
Engleson J, Soller M, Panagopoulos I, Dahlen A, Dictor M, Jerkeman M (2006) Midline carcinoma with t(15;19) and BRD4-NUT fusion oncogene in a 30-year-old female with response to docetaxel and radiotherapy. BMC Cancer 6:69. https://doi.org/10.1186/1471-2407-6-69
French CA (2012) Pathogenesis of NUT midline carcinoma. Annu Rev Pathol 7:247–265. https://doi.org/10.1146/annurev-pathol-011811-132438
French CA (2018) NUT Carcinoma: Clinicopathologic features, pathogenesis, and treatment. Pathol Int 68:583–595. https://doi.org/10.1111/pin.12727
French CA, Ramirez CL, Kolmakova J, Hickman TT, Cameron MJ, Thyne ME, Kutok JL, Toretsky JA, Tadavarthy AK, Kees UR, Fletcher JA, Aster JC (2008) BRD-NUT oncoproteins: a family of closely related nuclear proteins that block epithelial differentiation and maintain the growth of carcinoma cells. Oncogene 27:2237–2242. https://doi.org/10.1038/sj.onc.1210852
Hellquist H, French CA, Bishop JA, Coca-Pelaz A, Propst EJ, Paiva Correia A, Ngan BY, Grant R, Cipriani NA, Vokes D, Henrique R, Pardal F, Vizcaino JR, Rinaldo A, Ferlito A (2017) NUT midline carcinoma of the larynx: an international series and review of the literature. Histopathology 70:861–868. https://doi.org/10.1111/his.13143
Klijanienko J, Le Tourneau C, Rodriguez J, Caly M, Theocharis S (2016) Cytological features of NUT midline carcinoma arising in sino-nasal tract and parotid gland: report of two new cases and review of the literature. Diagn Cytopathol 44:753–756. https://doi.org/10.1002/dc.23506
Lemelle L, Pierron G, Freneaux P, Huybrechts S, Spiegel A, Plantaz D, Julieron M, Dumoucel S, Italiano A, Millot F, Le Tourneau C, Leverger G, Chastagner P, Carton M, Orbach D (2017) NUT carcinoma in children and adults: a multicenter retrospective study. Pediatr Blood Cancer 64.https://doi.org/10.1002/pbc.26693
Maher OM, Christensen AM, Yedururi S, Bell D, Tarek N (2015) Histone deacetylase inhibitor for NUT midline carcinoma. Pediatr Blood Cancer 62:715–717. https://doi.org/10.1002/pbc.25350
Napolitano M, Venturelli M, Molinaro E, Toss A (2019) NUT midline carcinoma of the head and neck: current perspectives. Onco Targets Ther 12:3235–3244. https://doi.org/10.2147/OTT.S173056
Patil VM, Toshniwal A, Noronha V, Joshi A, Menon N, Banavali S, Prabhash K (2019) NUT Midline Carcinoma. Clin Oncol (R Coll Radiol) 31:732. https://doi.org/10.1016/j.clon.2019.06.012
Schwartz BE, Hofer MD, Lemieux ME, Bauer DE, Cameron MJ, West NH, Agoston ES, Reynoird N, Khochbin S, Ince TA, Christie A, Janeway KA, Vargas SO, Perez-Atayde AR, Aster JC, Sallan SE, Kung AL, Bradner JE, French CA (2011) Differentiation of NUT midline carcinoma by epigenomic reprogramming. Cancer Res 71:2686–2696. https://doi.org/10.1158/0008-5472.CAN-10-3513
Serra C, Staartjes VE, Maldaner N, Holzmann D, Soyka MB, Gilone M, Schmid C, Tschopp O, Regli L (2020) Assessing the surgical outcome of the “chopsticks” technique in endoscopic transsphenoidal adenoma surgery. Neurosurg Focus 48:E15. https://doi.org/10.3171/2020.3.FOCUS2065
Stelow EB (2011) A review of NUT midline carcinoma. Head Neck Pathol 5:31–35. https://doi.org/10.1007/s12105-010-0235-x
Turcu AF, Erickson BJ, Lin E, Guadalix S, Schwartz K, Scheithauer BW, Atkinson JL, Young WF Jr (2013) Pituitary stalk lesions: the Mayo Clinic experience. J Clin Endocrinol Metab 98:1812–1818. https://doi.org/10.1210/jc.2012-4171
Author information
Authors and Affiliations
Contributions
All authors contributed to the study conception and design. Stefanos Voglis, Anna Maria Reuss and Elisabeth Jane Rushing performed the material preparation, data collection, and analysis. Lazar Tosic wrote the first draft of the manuscript and all the authors commented on previous versions. Carlo Serra and Luca Regli read and approved the final manuscript.
Corresponding author
Ethics declarations
Ethics approval
All procedures performed in studies involving human participants followed the ethical standards of the institutional and national research committee and the 1964 Helsinki Declaration and its later amendments or comparable ethical standards.
Consent to participate
The participant gave informed consent to be included in the study.
Conflict of interest
The authors declare that they have no conflict of interest.
Additional information
Publisher’s note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
This article is part of the Topical Collection on Pituitaries
Rights and permissions
About this article
Cite this article
Tosic, L., Voglis, S., Reuss, A.M. et al. Intra-, para-, and suprasellar nuclear protein of testis carcinoma with infiltration of cavernous sinus and clivus—a case report. Acta Neurochir 164, 1105–1110 (2022). https://doi.org/10.1007/s00701-021-05065-x
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00701-021-05065-x